MJ Nutra Recalls Champignons et Adaptogènes Due to Ingredient Concentration Discrepancies

What Happened

MJ Nutra has initiated a recall for one lot of its health product, Champignons et Adaptogènes. The recall was issued because the affected lot contains concentrations of certain ingredients that differ from the concentrations listed on the product label. This discrepancy was identified during a review of the product’s lot-specific data.

Which Products Are Affected

The recall specifically impacts the following product:

• Brand: MJ Nutra
• Product Name: Champignons et Adaptogènes
• Market Authorization (NPN): 80139467
• Dosage Form: Powder
• Affected Lot: 225107
• Labelled Ingredients: Astragalus membranaceus (472.5 mg), Eleutherococcus senticosus (940.0 mg), Ganoderma lucidum (200.0 mg), Hericium erinaceus (610.0 mg), Lepidium meyenii (1.89 g), Lycium barbarum (610.0 mg), Paecilomyces hepialid (710.0 mg), Panax ginseng (140.0 mg), Phyllanthus emblica (140.0 mg), Rhodiola rosea (410.0 mg), and Withania somnifera (2.65 g).

What You Should Do

Consumers are advised to verify if their product belongs to the affected lot (225107). Health Canada recommends consulting a healthcare provider before discontinuing the use of the product or if you have any health concerns related to its consumption.

For questions regarding the recall, consumers can contact MJ Nutra at 1335 rue René-Descartes, Saint-Bruno, QC, J3V 0B7. Any health product-related side effects or safety complaints should be reported directly to Health Canada.

Why This Matters

When the actual concentration of ingredients in a health supplement differs from the label, consumers may unknowingly ingest incorrect dosages. This can lead to unexpected side effects or a lack of intended therapeutic benefit.

Source

For more information, visit the official Health Canada recall notice.